Injective Token Surges 8.2% as Bullish Sentiment Drives Demand

Injective's recent price surge has caught the attention of investors, with the token experiencing an 8.2% increase in the past 24 hours. This rally has been driven by a significant rise in demand, particularly as the price challenged the $14 resistance zone. The surge in volume, which was nearly 40% higher than usual, indicates a strong bullish sentiment among traders.

The recent breakout past $14.4 has been identified as a good buying opportunity by on-chain metrics. This level is marked by the 78.6% Fibonacci retracement at $14.16, suggesting that the move beyond this point is a firm sign of bullish intent. The MACD indicator also flashed a bullish crossover, further supporting the momentum shift in favor of buyers.

Despite a slowdown in demand over the past two weeks, the overall trend remains positive. The A/D indicator has shown higher highs and higher lows since April, reflecting increased demand. The balance between bulls and bears is now more neutral, but the recent breach of the local $14.42 resistance level indicates that the bulls are still in control.

Injective's price chart illustrates a bullish bias in recent weeks, with the token forming a range below $11 in March and April. The rally was not random but came with rising volume and was backed by clear structure. The recent breakout saw some profit-taking in late April, but the metric is rising once more, reflecting network-wide accumulation.

The Mean Coin Age has been in an uptrend since late January, indicating that the token has been accumulating within a range for two months. The 180-day MVRV remaining in negative territory suggests that holders in this period are still at a loss on average, reducing the risk of profit-taking activity.

The development activity has been fairly steady in 2025, despite the volatile price trends. This is a positive sign for long-term investors, as it indicates ongoing development and support for the token. The steady daily active addresses and development activity on-chain are also encouraging factors, suggesting that Injective presents a buying opportunity.

Injective traders might not want to wait for lofty targets. On Bybit’s Liquidation Heatmap, a dense cluster appeared around $15-$15.5 and could pull INJ higher. Thereafter, the token might need time for consolidation before its next impulse move higher. This is the move that metrics signaled investors could buy.